Agios Pharmaceuticals, Inc. · NASDAQ:AGIO
Morgan Stanley reported a 5.70% stake in Agios Pharmaceuticals, Inc. (Schedule 13G)
Event Sep 30, 2026 · Filed Nov 13, 2026
Morgan Stanley reported a 5.70% stake in Agios Pharmaceuticals, Inc., 3,431,830 shares, as a passive investor on Sep 30, 2026. Filed Nov 13, 2026 (Schedule 13G).
- Stake
- 5.70%
- Shares
- 3,431,830
- Intent
- Passive
- What changed
- Crossed above 5%
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| Morgan Stanley | 5.70% | 3,431,830 |
Source
Download original · View original at SEC
Related
- Agios Pharmaceuticals, Inc.
- Morgan Stanley
- Agios Pharmaceuticals, Inc. shareholders
- Schedule 13G/A · Lynx1 Capital Management LP · Nov 16, 2026
- Schedule 13G/A · D. E. Shaw & Co., L.P. · Nov 16, 2026
- Form 4 · Gheuens Sarah · Oct 28, 2026
- Form 4 · Gheuens Sarah · Oct 23, 2026
- Form 4 · Gheuens Sarah · Aug 6, 2026